Paid stock option plan subject to performance conditions
First written in FY2021-Q3. 4 of 10 entries say "Dropped", first in FY2022-Q3. Latest entry: FY2026.
0 other companies' latest entry also says "Achieved".
- FY2026AchievedAnnual report
「Before vesting (shares) End of previous consolidated fiscal year 300,000 Granted — Forfeited 300,000 Vested — Outstanding unvested balance —」
The share acquisition rights covering 300,000 shares and subject to net sales exceeding ¥3,500 million no longer remained outstanding at the end of the current period because they expired. - FY2025Plan terms and outstanding unvested balance disclosed againAnnual report
「Performance target: Net sales exceeding ¥3,500 million Exercise period for share acquisition rights* From 1 February 2021 to 31 January 2026」
Regarding the stock options that had previously been stated as not applicable in a quarterly disclosure, 300,000 shares are listed as an outstanding unvested balance as of the end of the current period. - FY2025-H1DroppedAnnual report
「① Details of the stock option plan There are no applicable matters. ② Status of other stock acquisition rights, etc. There are no applicable matters.」
The interim-period Securities and Other Information section states that there are no applicable stock option plans or other share acquisition rights. - FY2024Annual red disclosure of plan termsAnnual report
「Performance target: Net sales exceeding ¥3,500 million Exercise period for share acquisition rights* From 1 February 2021 to 31 January 2026」
Regarding the paid stock options subject to performance conditions that had previously been stated as not applicable in a quarterly disclosure, the annual disclosure describes 100 options covering 300,000 shares, the condition of net sales exceeding ¥3,500 million and other terms. - FY2024-Q2DroppedAnnual report
「① Details of the stock option plan There are no applicable matters. ② Status of other stock acquisition rights, etc. There are no applicable matters.」
The current-quarter Securities and Other Information section states that there are no applicable stock option plans or other share acquisition rights. - FY2023Plan terms disclosed againAnnual report
「Performance target: Net sales exceeding ¥3,500 million Exercise period for share acquisition rights* From 1 February 2021 to 31 January 2026」
Regarding the paid stock options subject to performance conditions that were stated as not applicable in the previous quarter, the annual disclosure again describes 100 options covering 300,000 shares, the condition of net sales exceeding ¥3,500 million and other terms. - FY2023-Q2DroppedAnnual report
「① Details of the stock option plan There are no applicable matters. ② Status of other stock acquisition rights, etc. There are no applicable matters.」
Regarding the paid stock options subject to performance conditions described in the previous fiscal year, the current-quarter Securities and Other Information section states that there are no applicable stock option plans or other share acquisition rights. - FY2022RestatedAnnual report
「Performance target: Net sales exceeding ¥3,500 million Exercise period for share acquisition rights* From 1 February 2021 to 31 January 2026」
Regarding the paid stock options subject to performance conditions that were stated as not applicable in the previous quarter, the current fiscal year's Securities and Other Information section again describes the plan's terms. - FY2022-Q3DroppedAnnual report
「① Details of the stock option plan There are no applicable matters. ② Status of other stock acquisition rights, etc. There are no applicable matters.」
Regarding the paid stock options subject to performance conditions disclosed previously, the current-quarter Securities and Other Information section states that there are no applicable stock option plans or other share acquisition rights. - FY2021-Q3First statedAnnual report
「At a meeting of the Board of Directors held on 21 December 2020, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue paid stock options (share acquisition rights) subject to performance conditions to its directors, with 31 January 2021 as the allotment date. Performance target: Net sales exceeding ¥3,500 million Exercise period for share acquisition rights* From 1 February 2021 to 31 January 2026」
The company resolved to issue 100 paid stock options subject to performance conditions, covering 100,000 shares, to 5 directors. The exercise condition was set at net sales exceeding ¥3,500 million, and the exercise period was set from 1 February 2021 to 31 January 2026.